World City Press – Lifestyle
Author:
Grace Therapeutics, Inc.
Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
April 23, 2026
Grace Therapeutics Announces Abstract Highlighting STRIVE-ON Phase 3 Trial Results Accepted for Presentation at AAN 2026
April 14, 2026
Grace Therapeutics to Present Data on the Unmet Medical Needs and Potential Benefits of GTx-104 in the Treatment of aSAH at Upcoming Medical Conferences
March 19, 2026